Vor Biopharma Inc. (NASDAQ:VOR), a clinical-stage biopharmaceutical firm with a market capitalization of roughly $80 million, focuses on growing therapies…
BEIJING (Reuters) - China's gross home product is predicted to develop by round 5% in 2024, President Xi Jinping stated…
Investing.com– Gold costs have been largely unchanged in Asian commerce on Tuesday amid skinny year-end buying and selling, though they…
Investing.com -- European Central Financial institution (ECB) Governing Council member Yannis Stournaras has indicated that the financial institution's reductions in…
In a current submitting with the Securities and Alternate Fee, the W.Ok. Kellogg (NYSE:Ok) Basis Belief disclosed a major sale…
Legend Biotech Company (NASDAQ:LEGN) has captured the eye of buyers and analysts alike with its modern CAR-T remedy, Carvykti, which…
Investing.com-- Most Asian currencies edged decrease on Tuesday and headed for yearly losses because the greenback remained sturdy heading into…
Investing.com – Worldwide Enterprise Machines’ deliberate takeover of HashiCorp (NASDAQ:HCP) might be underneath risk after the UK’s antitrust watchdog mentioned…
Adam Stedham, CEO and President of VerifyMe, Inc. (NASDAQ:VRME), lately acquired 22,000 shares of the corporate's frequent inventory. The transaction,…
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) is a clinical-stage biotechnology firm that has captured the eye of buyers and analysts alike with…